A citation-based method for searching scientific literature

Peixin Chen, Yunhuan Liu, Yaokai Wen, Caicun Zhou. Cancer Commun (Lond) 2022
Times Cited: 2







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
100

The Effect of Advances in Lung-Cancer Treatment on Population Mortality.
Nadia Howlader, Gonçalo Forjaz, Meghan J Mooradian, Rafael Meza, Chung Yin Kong, Kathleen A Cronin, Angela B Mariotto, Douglas R Lowy, Eric J Feuer. N Engl J Med 2020
471
100

Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer.
Takashi Kohno, Takashi Nakaoku, Koji Tsuta, Katsuya Tsuchihara, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto. Transl Lung Cancer Res 2015
156
50


Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).
Peter B Bach, Gerard A Silvestri, Morgan Hanger, James R Jett. Chest 2007
107
50

Radiation exposure and lung disease in today's nuclear world.
Steven D Deas, Nikhil Huprikar, Andrew Skabelund. Curr Opin Pulm Med 2017
10
50

Kurtosis and skewness assessments of solid lung nodule density histograms: differentiating malignant from benign nodules on CT.
Ayano Kamiya, Sadayuki Murayama, Hisashi Kamiya, Tsuneo Yamashiro, Yasuji Oshiro, Nobuyuki Tanaka. Jpn J Radiol 2014
32
50

Cancer risks after radiation exposure in middle age.
Igor Shuryak, Rainer K Sachs, David J Brenner. J Natl Cancer Inst 2010
127
50

EGFR and ERBB2 Germline Mutations in Chinese Lung Cancer Patients and Their Roles in Genetic Susceptibility to Cancer.
Shun Lu, Yongfeng Yu, Ziming Li, Ruoying Yu, Xue Wu, Hairong Bao, Yan Ding, Yang W Shao, Hong Jian. J Thorac Oncol 2019
30
50

Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non-Small Cell Lung Cancer: The ALTER 0303 Phase 3 Randomized Clinical Trial.
Baohui Han, Kai Li, Qiming Wang, Li Zhang, Jianhua Shi, Zhehai Wang, Ying Cheng, Jianxing He, Yuankai Shi, Yizhuo Zhao,[...]. JAMA Oncol 2018
272
50

Brigatinib: First Global Approval.
Anthony Markham. Drugs 2017
62
50

MassARRAY, pyrosequencing, and PNA clamping for EGFR mutation detection in lung cancer tissue and cytological samples: a multicenter study.
Kyueng-Whan Min, Wan-Seop Kim, Se Jin Jang, Yoo Duk Choi, Sunhee Chang, Soon Hee Jung, Lucia Kim, Mee-Sook Roh, Choong Sik Lee, Jung Weon Shim,[...]. J Cancer Res Clin Oncol 2016
9
50

Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration.
Alexander Drilon, Jeffrey W Clark, Jared Weiss, Sai-Hong Ignatius Ou, D Ross Camidge, Benjamin J Solomon, Gregory A Otterson, Liza C Villaruz, Gregory J Riely, Rebecca S Heist,[...]. Nat Med 2020
168
50

Stressful social relations and mortality: a prospective cohort study.
Rikke Lund, Ulla Christensen, Charlotte Juul Nilsson, Margit Kriegbaum, Naja Hulvej Rod. J Epidemiol Community Health 2014
19
50

Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors.
Eilon D Kirson, Vladimír Dbalý, Frantisek Tovarys, Josef Vymazal, Jean F Soustiel, Aviran Itzhaki, Daniel Mordechovich, Shirley Steinberg-Shapira, Zoya Gurvich, Rosa Schneiderman,[...]. Proc Natl Acad Sci U S A 2007
424
50

[Risk Factors of Lung Cancer in Xuanwei, Yunnan Province, China].
Liqun Liu, Xia Wan, Gongbo Chen, Xiangyun Ma, Bofu Ning, Gonghuan Yang. Zhongguo Fei Ai Za Zhi 2017
2
50

Identification of the Unique Clinical and Genetic Features of Chinese Lung Cancer Patients With EGFR Germline Mutations in a Large-Scale Retrospective Study.
Xinqing Lin, Muyun Peng, Quanfang Chen, Mingming Yuan, Rongrong Chen, Haiyi Deng, Jiaxi Deng, Ouqi Liu, Yuqing Weng, Mingjiu Chen,[...]. Front Oncol 2021
1
100

Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study.
Keunchil Park, Eric B Haura, Natasha B Leighl, Paul Mitchell, Catherine A Shu, Nicolas Girard, Santiago Viteri, Ji-Youn Han, Sang-We Kim, Chee Khoon Lee,[...]. J Clin Oncol 2021
134
50

Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial.
Mariano Provencio, Ernest Nadal, Amelia Insa, María Rosario García-Campelo, Joaquín Casal-Rubio, Manuel Dómine, Margarita Majem, Delvys Rodríguez-Abreu, Alex Martínez-Martí, Javier De Castro Carpeño,[...]. Lancet Oncol 2020
260
50

Three-Year Follow-Up of a Randomized Phase II Trial on Refinement of Early-Stage NSCLC Adjuvant Chemotherapy with Cisplatin and Pemetrexed versus Cisplatin and Vinorelbine (the TREAT Study).
Michael Kreuter, Johan Vansteenkiste, Jürgen R Fischer, Wilfried E Eberhardt, Heike Zabeck, Jens Kollmeier, Monika Serke, Norbert Frickhofen, Martin Reck, Walburga Engel-Riedel,[...]. J Thorac Oncol 2016
23
50

Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study.
Philip C Haycock, Stephen Burgess, Aayah Nounu, Jie Zheng, George N Okoli, Jack Bowden, Kaitlin Hazel Wade, Nicholas J Timpson, David M Evans, Peter Willeit,[...]. JAMA Oncol 2017
257
50

Prognostic Impact of KRAS G12C Mutation in Patients With NSCLC: Results From the European Thoracic Oncology Platform Lungscape Project.
Stephen P Finn, Alfredo Addeo, Urania Dafni, Erik Thunnissen, Lukas Bubendorf, Line Bille Madsen, Wojciech Biernat, Eric Verbeken, Javier Hernandez-Losa, Antonio Marchetti,[...]. J Thorac Oncol 2021
21
50

The mortality of lung cancer attributable to smoking among adults in China and the United States during 1990-2017.
Xiaoxue Liu, Yong Yu, Minsheng Wang, Sumaira Mubarik, Fang Wang, Yafeng Wang, Runtang Meng, Chuanhua Yu. Cancer Commun (Lond) 2020
20
50

Folate receptor-positive circulating tumor cells as a novel diagnostic biomarker in non-small cell lung cancer.
Yue Yu, Zhaoli Chen, Jingsi Dong, Peng Wei, Rongjun Hu, Chengcheng Zhou, Nan Sun, Mei Luo, Wenjing Yang, Ran Yao,[...]. Transl Oncol 2013
73
50

Efficacy and Safety of Necitumumab Continuation Therapy in the Phase III SQUIRE Study of Patients With Stage IV Squamous Non-Small-Cell Lung Cancer.
Tudor Ciuleanu, Mark A Socinski, Coleman Obasaju, Alexander V Luft, Aleksandra Szczesna, Wojciech Szafrański, Rodryg Ramlau, Beatrix Bálint, Olivier Molinier, Henrik Depenbrock,[...]. Clin Lung Cancer 2018
12
50

Comprehensive investigation of oncogenic driver mutations in Chinese non-small cell lung cancer patients.
Rui Wang, Yang Zhang, Yunjian Pan, Yuan Li, Haichuan Hu, Deng Cai, Hang Li, Ting Ye, Xiaoyang Luo, Yiliang Zhang,[...]. Oncotarget 2015
64
50

Treatment Outcomes and Safety of Mobocertinib in Platinum-Pretreated Patients With EGFR Exon 20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer: A Phase 1/2 Open-label Nonrandomized Clinical Trial.
Caicun Zhou, Suresh S Ramalingam, Tae Min Kim, Sang-We Kim, James Chih-Hsin Yang, Gregory J Riely, Tarek Mekhail, Danny Nguyen, Maria R Garcia Campelo, Enriqueta Felip,[...]. JAMA Oncol 2021
69
50


Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.
Joan H Schiller, David Harrington, Chandra P Belani, Corey Langer, Alan Sandler, James Krook, Junming Zhu, David H Johnson. N Engl J Med 2002
50

Protocol for the examination of specimens from patients with primary non-small cell carcinoma, small cell carcinoma, or carcinoid tumor of the lung.
Kelly J Butnor, Mary Beth Beasley, Philip T Cagle, Steven M Grunberg, Feng-Ming Kong, Alberto Marchevsky, Nader T Okby, Victor L Roggli, Saul Suster, Henry D Tazelaar,[...]. Arch Pathol Lab Med 2009
18
50

Clinical efficacy of atezolizumab plus bevacizumab and chemotherapy in KRAS-mutated non-small cell lung cancer with STK11, KEAP1, or TP53 comutations: subgroup results from the phase III IMpower150 trial.
Howard Jack West, Mark McCleland, Federico Cappuzzo, Martin Reck, Tony Sk Mok, Robert M Jotte, Makoto Nishio, Eugene Kim, Stefanie Morris, Wei Zou,[...]. J Immunother Cancer 2022
16
50

Pembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer: The Phase 2 KEYNOTE-799 Nonrandomized Trial.
Salma K Jabbour, Ki Hyeong Lee, Nikolaj Frost, Valeriy Breder, Dariusz M Kowalski, Theodore Pollock, Evgeny Levchenko, Noemi Reguart, Alex Martinez-Marti, Baerin Houghton,[...]. JAMA Oncol 2021
43
50

Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR-Based Method as a Diagnostic Biomarker for Non-Small-Cell Lung Cancer.
Xiaoxia Chen, Fei Zhou, Xuefei Li, Guohua Yang, Ling Zhang, Shengxiang Ren, Chao Zhao, Qinfang Deng, Wei Li, Guanghui Gao,[...]. J Thorac Oncol 2015
80
50

Neoadjuvant immunotherapy for non-small cell lung cancer: State of the art.
Jin Kang, Chao Zhang, Wen-Zhao Zhong. Cancer Commun (Lond) 2021
37
50

Lung Cancer in People's Republic of China.
Shugeng Gao, Ning Li, Shuhang Wang, Fan Zhang, Wenqiang Wei, Ni Li, Nan Bi, Zhijie Wang, Jie He. J Thorac Oncol 2020
61
50


The Advent of Ultra-high Volume Thoracic Surgical Centers in Shanghai.
Alan D L Sihoe, Baohui Han, Timothy Y Yang, Changqing Pan, Gening Jiang, Vincent W T Fang. World J Surg 2017
12
50

Smoking prevalence and cigarette consumption in 187 countries, 1980-2012.
Marie Ng, Michael K Freeman, Thomas D Fleming, Margaret Robinson, Laura Dwyer-Lindgren, Blake Thomson, Alexandra Wollum, Ella Sanman, Sarah Wulf, Alan D Lopez,[...]. JAMA 2014
980
50

Sotorasib for Lung Cancers with KRAS p.G12C Mutation.
Ferdinandos Skoulidis, Bob T Li, Grace K Dy, Timothy J Price, Gerald S Falchook, Jürgen Wolf, Antoine Italiano, Martin Schuler, Hossein Borghaei, Fabrice Barlesi,[...]. N Engl J Med 2021
349
50

Pyrotinib in HER2-Mutant Advanced Lung Adenocarcinoma After Platinum-Based Chemotherapy: A Multicenter, Open-Label, Single-Arm, Phase II Study.
Caicun Zhou, Xingya Li, Qiming Wang, Guanghui Gao, Yiping Zhang, Jianhua Chen, Yongqian Shu, Yanping Hu, Yun Fan, Jian Fang,[...]. J Clin Oncol 2020
76
50

Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer.
Jürgen Wolf, Takashi Seto, Ji-Youn Han, Noemi Reguart, Edward B Garon, Harry J M Groen, Daniel S W Tan, Toyoaki Hida, Maja de Jonge, Sergey V Orlov,[...]. N Engl J Med 2020
308
50


Expert consensus on neoadjuvant immunotherapy for non-small cell lung cancer.
Wenhua Liang, Kaican Cai, Chun Chen, Haiquan Chen, Qixun Chen, Junke Fu, Jian Hu, Tao Jiang, Wenjie Jiao, Shuben Li,[...]. Transl Lung Cancer Res 2020
21
50

EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer.
Jussi P Koivunen, Craig Mermel, Kreshnik Zejnullahu, Carly Murphy, Eugene Lifshits, Alison J Holmes, Hwan Geun Choi, Jhingook Kim, Derek Chiang, Roman Thomas,[...]. Clin Cancer Res 2008
754
50

Comparison of genetic profiles among primary lung tumor, metastatic lymph nodes and circulating tumor DNA in treatment-naïve advanced non-squamous non-small cell lung cancer patients.
Fangfang Xie, Yujun Zhang, Xiaowei Mao, Xiaoxuan Zheng, Han Han-Zhang, Junyi Ye, Ruiying Zhao, Xueyan Zhang, Jiayuan Sun. Lung Cancer 2018
18
50

Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small-cell lung cancer.
Toshimi Takano, Yuichiro Ohe, Hiromi Sakamoto, Koji Tsuta, Yoshihiro Matsuno, Ukihide Tateishi, Seiichiro Yamamoto, Hiroshi Nokihara, Noboru Yamamoto, Ikuo Sekine,[...]. J Clin Oncol 2005
608
50

Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations.
Paul K Paik, Enriqueta Felip, Remi Veillon, Hiroshi Sakai, Alexis B Cortot, Marina C Garassino, Julien Mazieres, Santiago Viteri, Helene Senellart, Jan Van Meerbeeck,[...]. N Engl J Med 2020
281
50

Clinicopathologic features of non-small-cell lung cancer with EML4-ALK fusion gene.
Tsuyoshi Takahashi, Makoto Sonobe, Masashi Kobayashi, Akihiko Yoshizawa, Toshi Menju, Ei Nakayama, Nobuya Mino, Shotaro Iwakiri, Kiyoshi Sato, Ryo Miyahara,[...]. Ann Surg Oncol 2010
260
50

Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC.
Suresh S Ramalingam, Johan Vansteenkiste, David Planchard, Byoung Chul Cho, Jhanelle E Gray, Yuichiro Ohe, Caicun Zhou, Thanyanan Reungwetwattana, Ying Cheng, Busyamas Chewaskulyong,[...]. N Engl J Med 2020
50

Osimertinib Versus Comparator EGFR TKI as First-Line Treatment for EGFR-Mutated Advanced NSCLC: FLAURA China, A Randomized Study.
Ying Cheng, Yong He, Wei Li, He-Long Zhang, Qing Zhou, Buhai Wang, Chunling Liu, Andrew Walding, Matilde Saggese, Xiangning Huang,[...]. Target Oncol 2021
35
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.